A Survey on Pituitary Surgery in Italy.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 02 08 2018
revised: 19 11 2018
accepted: 20 11 2018
pubmed: 1 12 2018
medline: 2 4 2019
entrez: 1 12 2018
Statut: ppublish

Résumé

Pituitary tumors are a heterogeneous group of lesions that are usually benign. Therefore, a proper understanding of the anatomy, physiology, and pathology is mandatory to achieve favorable outcomes. Accordingly, diagnostic tests and treatment guidelines should be determined and implemented. Thus, we decided to perform a multicenter study among Italian neurosurgical centers performing pituitary surgery to provide an actual depiction from the neurosurgical standpoint. On behalf of the SINch (Società Italiana di Neurochirurgia), a survey was undertaken with the participants to explore the activities in the field of pituitary surgery within 41 public institutions. Of the 41 centers, 37 participated in the present study. The total number of neurosurgical procedures performed in 2016 was 1479. Most of the procedures were performed using the transsphenoidal approach (1320 transsphenoidal [1204 endoscopic, 53 microscopic, 53 endoscope-assisted microscopic] vs. 159 transcranial). A multidisciplinary tumor board is convened regularly in 32 of 37 centers, and a research laboratory is present in 18 centers. Diagnosing pituitary/hypothalamus disorders and treating them is the result of teamwork, composed of several diverse experts. Regarding neurosurgery, our findings have confirmed the central role of the transsphenoidal approach, with preference toward the endoscopic technique. Better outcomes can be expected at centers with a multidisciplinary team and a full, or part of a, residency program, with a greater surgical caseload.

Sections du résumé

BACKGROUND BACKGROUND
Pituitary tumors are a heterogeneous group of lesions that are usually benign. Therefore, a proper understanding of the anatomy, physiology, and pathology is mandatory to achieve favorable outcomes. Accordingly, diagnostic tests and treatment guidelines should be determined and implemented. Thus, we decided to perform a multicenter study among Italian neurosurgical centers performing pituitary surgery to provide an actual depiction from the neurosurgical standpoint.
METHODS METHODS
On behalf of the SINch (Società Italiana di Neurochirurgia), a survey was undertaken with the participants to explore the activities in the field of pituitary surgery within 41 public institutions.
RESULTS RESULTS
Of the 41 centers, 37 participated in the present study. The total number of neurosurgical procedures performed in 2016 was 1479. Most of the procedures were performed using the transsphenoidal approach (1320 transsphenoidal [1204 endoscopic, 53 microscopic, 53 endoscope-assisted microscopic] vs. 159 transcranial). A multidisciplinary tumor board is convened regularly in 32 of 37 centers, and a research laboratory is present in 18 centers.
CONCLUSIONS CONCLUSIONS
Diagnosing pituitary/hypothalamus disorders and treating them is the result of teamwork, composed of several diverse experts. Regarding neurosurgery, our findings have confirmed the central role of the transsphenoidal approach, with preference toward the endoscopic technique. Better outcomes can be expected at centers with a multidisciplinary team and a full, or part of a, residency program, with a greater surgical caseload.

Identifiants

pubmed: 30500583
pii: S1878-8750(18)32745-1
doi: 10.1016/j.wneu.2018.11.186
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e440-e449

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Domenico Solari (D)

Division of Neurosurgery, Università degli Studi di Napoli "Federico II", Naples, Italy. Electronic address: domenico.solari@unina.it.

Francesco Zenga (F)

Division of Neurosurgery, Università degli Studi di Torino - Città della Salute e della Scienza, Turin, Italy.

Filippo F Angileri (FF)

Division of Neurosurgery, Università degli Studi di Messina - Policlinico "G. Martino", Messina, Italy.

Andrea Barbanera (A)

Division of Neurosurgery, AO "SS. Antonio e Biagio e Cesare Arrigo", Alessandria, Italy.

Silvia Berlucchi (S)

Division of Neurosurgery, AOU Ospedale Civile di Baggiovara, Modena, Italy.

Claudio Bernucci (C)

Division of Neurosurgery, ASST "Papa Giovanni XXIII", Bergamo, Italy.

Carmine Carapella (C)

Division of Neurosurgery, IRCCS Istituto Nazionale Tumori "Regina Elena", Rome, Italy.

Domenico Catapano (D)

Division of Neurosurgery, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.

Giuseppe Catapano (G)

Division of Neurosurgery, AO "G. Rummo", Benevento, Italy.

Luigi M Cavallo (LM)

Division of Neurosurgery, Università degli Studi di Napoli "Federico II", Naples, Italy.

Corrado D'Arrigo (C)

Division of Neurosurgery, AO "Cannizzaro", Catania, Italy.

Michelangelo de Angelis (M)

Division of Neurosurgery, IRCCS Neuromed, Pozzilli, Italy.

Luca Denaro (L)

Division of Neurosurgery, Università degli Studi di Padova, Padua, Italy.

Nicola Desogus (N)

Division of Neurosurgery, AO "G. Brotzu", Cagliari, Italy.

Paolo Ferroli (P)

Division of Neurosurgery (NCH 2), Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milan, Italy.

Marco M Fontanella (MM)

Division of Neurosurgery, Università degli Studi di Brescia - Spedali Civili, Brescia, Italy.

Renato J Galzio (RJ)

Division of Neurosurgery, Università degli Studi - Ospedale Civile "S. Salvatore", L'Aquila, Italy; Division of Neurosurgery, Università degli Studi di Pavia - Fondazione IRCCS Policlinico "S. Matteo", Pavia, Italy.

Cosimo D Gianfreda (CD)

Division of Neurosurgery, Presidio Ospedaliero "V. Fazzi", Lecce, Italy.

Maurizio Iacoangeli (M)

Division of Neurosurgery, Università Politecnica delle Marche - Ospedali Riuniti Torrette, Ancona, Italy.

Liverana Lauretti (L)

Division of Neurosurgery, Università Cattolica del Sacro Cuore - Policlinico "A. Gemelli", Rome, Italy.

Davide Locatelli (D)

Division of Neurosurgery, Università degli Studi dell'Insubria, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.

Marco Locatelli (M)

Division of Neurosurgery, Fondazione IRCCS Cà Granda - Ospedale Maggiore - Policlinico, Milan, Italy.

Davide Luglietto (D)

Division of Neurosurgery, AOU Senese "Le Scotte", Siena, Italy.

Diego Mazzatenta (D)

Division of Neurosurgery, IRCCS Isituto delle Scienze Neurologiche, Ospedale Bellaria, Bologna, Italy.

Agazio Menniti (A)

Division of Neurosurgery, AO "San Camillo-Forlanini", Rome, Italy.

Davide Milani (D)

Division of Neurosurgery, Humanitas Research Hospital, Rozzano, Italy.

Maria Teresa Nasi (MT)

Division of Neurosurgery, AO "M. Bufalini", Cesena, Italy.

Antonio Romano (A)

Division of Neurosurgery, AOU Parma-Reggio Emilia, Italy.

Andrea G Ruggeri (AG)

Division of Neurosurgery, Università degli Studi di Roma "La Sapienza", Rome, Italy.

Andrea Saladino (A)

Division of Neurosurgery (NCH 1), Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milan, Italy.

Orazio Santonocito (O)

Division of Neurosurgery, Spedali Riuniti di Livorno - USL Toscana Nord-Ovest, Livorno, Italy.

Andreas Schwarz (A)

Division of Neurosurgery, Ospedale di Bolzano, Bolzano, Italy.

Miran Skrap (M)

Division of Neurosurgery, AOU di Udine, Udine, Italy.

Roberto Stefini (R)

Division of Neurosurgery, AO Ospedale Civile di Legnano, Legnano, Italy.

Lorenzo Volpin (L)

Division of Neurosurgery, Ospedale San Bortolo, Vicenza, Italy.

Giulio C Wembagher (GC)

Division of Neurosurgery, AOU "Careggi", Firenze, Italy.

Cesare Zoia (C)

Division of Neurosurgery, Università degli Studi di Pavia - Fondazione IRCCS Policlinico "S. Matteo", Pavia, Italy.

Gianluigi Zona (G)

Division of Neurosurgery, Università degli Studi di Genova - Ospedale "San Martino", Genoa, Italy.

Paolo Cappabianca (P)

Division of Neurosurgery, Università degli Studi di Napoli "Federico II", Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH